Daniela Fera, Ph.D.
Affiliations: | 2012 | Chemistry | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biological ChemistryGoogle:
"Daniela Fera"Mean distance: 9.66 | S | N | B | C | P |
Parents
Sign in to add mentorRonen Marmorstein | grad student | 2012 | Penn | |
(Identification and characterization of small molecule antagonists of the human papillomavirus oncoproteins.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nguyen D, Lin LY, Zhou JO, et al. (2020) Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling. Biochemistry |
Fera D, Lee MS, Wiehe K, et al. (2018) HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope. Nature Communications. 9: 1111 |
Williams WB, Zhang J, Jiang C, et al. (2017) Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations. Nature Communications. 8: 1732 |
Bonsignori M, Kreider EF, Fera D, et al. (2017) Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Science Translational Medicine. 9 |
Easterhoff D, Moody MA, Fera D, et al. (2017) Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. Plos Pathogens. 13: e1006182 |
Bradley T, Fera D, Bhiman J, et al. (2015) Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. Cell Reports |
Fera D, Schmidt AG, Haynes BF, et al. (2014) Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains. Proceedings of the National Academy of Sciences of the United States of America. 111: 10275-80 |
Malecka KA, Fera D, Schultz DC, et al. (2014) Identification and characterization of small molecule human papillomavirus E6 inhibitors. Acs Chemical Biology. 9: 1603-12 |
Fera D, Marmorstein R. (2012) Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300. Biochemistry. 51: 9524-34 |
Fera D, Schultz DC, Hodawadekar S, et al. (2012) Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins. Chemistry & Biology. 19: 518-28 |